Cravath and Cadwalader snare key roles on $16.6bn Johnson & Johnson deal
New York firms Cravath Swaine & Moore and Cadwalader Wickersham & Taft have both grabbed the top roles on Johnson & Johnson’s $16.6bn acquisition of Pfizer Consumer Healthcare. Cravath partner George Schoen said old connections helped the firm win its role: “Johnson & Johnson is a long term client of Cravath. It’s a carve-out business […]